Rituximab for humoral rejection after kidney transplantation: an update.
Rostaing
Lionel
L
Guilbeau-Frugier
Céline
C
Kamar
Nassim
N
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000917:Antibody Formation / Q000187:drug effects*; D001402:B-Lymphocytes / Q000276:immunology; D003131:Combined Modality Therapy; D006084:Graft Rejection / Q000188:drug therapy / Q000628:therapy*; D006650:Histocompatibility Testing; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D010956:Plasmapheresis; D000069283:Rituximab; D013601:T-Lymphocytes / Q000276:immunology
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab